Inflexion acquires Rosemont Pharmaceuticals
Inflexion has agreed to acquire Rosemont Pharmaceuticals, the UK’s leading liquid pharmaceuticals business. The business will be carved out from US listed company, Perrigo. Rosemont’s portfolio of over 130 oral liquid medicines includes over 70 licensed products which are sold into the UK as well as the US, Continental Europe and

